About
Sonic Incytes develops Velacur ONE, an AI-guided point-of-care ultrasound elastography device that measures liver elasticity and attenuation to assess chronic liver diseases (e.g., MASLD/MASH); the device is clinically validated and has received FDA 510(k) clearance.
Explore Sonic Incytes's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.